Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFα inhibitor in SCID mice with HIV-1 encephalitis

Y. Persidsky, J. Limoges, J. Rasmussen, Jialin C Zheng, A. Gearing, Howard Eliot Gendelman

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The effects of anti-inflammatory drugs on glial immunity and neuropathology were determined in a severe combined immune deficiency (SCID) mouse model of HIV-1 encephalitis. HIV-1-infected human monocyte-derived macrophages (MDM) are stereotactically inoculated into basal ganglia resulting in a multinucleated giant cell encephalitis. A platelet activating factor antagonist and a matrix metalloproteinase inhibitor, which also inhibits tumor necrosis factor alpha release, were administered to animals at the time of the MDM inoculation. The drugs administered in combination markedly reduced brain inflammation, astrogliosis and microglia activation. These findings demonstrate that reduction of brain inflammatory responses, independent of viral replication, can affect HIVE pathology in an animal model system of disease.

Original languageEnglish (US)
Pages (from-to)57-68
Number of pages12
JournalJournal of Neuroimmunology
Volume114
Issue number1-2
DOIs
StatePublished - Mar 1 2001

Fingerprint

Severe Combined Immunodeficiency
Matrix Metalloproteinase Inhibitors
Encephalitis
Neuroglia
HIV-1
Immunity
Macrophages
Animal Disease Models
Platelet Activating Factor
Microglia
Giant Cells
Basal Ganglia
Pharmaceutical Preparations
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Pathology
Brain
Neuropathology

Keywords

  • Anti-inflammatory drugs
  • HIV-1 encephalitis
  • Mononuclear phagocytes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFα inhibitor in SCID mice with HIV-1 encephalitis. / Persidsky, Y.; Limoges, J.; Rasmussen, J.; Zheng, Jialin C; Gearing, A.; Gendelman, Howard Eliot.

In: Journal of Neuroimmunology, Vol. 114, No. 1-2, 01.03.2001, p. 57-68.

Research output: Contribution to journalArticle

@article{ac45670cf15347afa93c900352f3977c,
title = "Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFα inhibitor in SCID mice with HIV-1 encephalitis",
abstract = "The effects of anti-inflammatory drugs on glial immunity and neuropathology were determined in a severe combined immune deficiency (SCID) mouse model of HIV-1 encephalitis. HIV-1-infected human monocyte-derived macrophages (MDM) are stereotactically inoculated into basal ganglia resulting in a multinucleated giant cell encephalitis. A platelet activating factor antagonist and a matrix metalloproteinase inhibitor, which also inhibits tumor necrosis factor alpha release, were administered to animals at the time of the MDM inoculation. The drugs administered in combination markedly reduced brain inflammation, astrogliosis and microglia activation. These findings demonstrate that reduction of brain inflammatory responses, independent of viral replication, can affect HIVE pathology in an animal model system of disease.",
keywords = "Anti-inflammatory drugs, HIV-1 encephalitis, Mononuclear phagocytes",
author = "Y. Persidsky and J. Limoges and J. Rasmussen and Zheng, {Jialin C} and A. Gearing and Gendelman, {Howard Eliot}",
year = "2001",
month = "3",
day = "1",
doi = "10.1016/S0165-5728(00)00454-9",
language = "English (US)",
volume = "114",
pages = "57--68",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFα inhibitor in SCID mice with HIV-1 encephalitis

AU - Persidsky, Y.

AU - Limoges, J.

AU - Rasmussen, J.

AU - Zheng, Jialin C

AU - Gearing, A.

AU - Gendelman, Howard Eliot

PY - 2001/3/1

Y1 - 2001/3/1

N2 - The effects of anti-inflammatory drugs on glial immunity and neuropathology were determined in a severe combined immune deficiency (SCID) mouse model of HIV-1 encephalitis. HIV-1-infected human monocyte-derived macrophages (MDM) are stereotactically inoculated into basal ganglia resulting in a multinucleated giant cell encephalitis. A platelet activating factor antagonist and a matrix metalloproteinase inhibitor, which also inhibits tumor necrosis factor alpha release, were administered to animals at the time of the MDM inoculation. The drugs administered in combination markedly reduced brain inflammation, astrogliosis and microglia activation. These findings demonstrate that reduction of brain inflammatory responses, independent of viral replication, can affect HIVE pathology in an animal model system of disease.

AB - The effects of anti-inflammatory drugs on glial immunity and neuropathology were determined in a severe combined immune deficiency (SCID) mouse model of HIV-1 encephalitis. HIV-1-infected human monocyte-derived macrophages (MDM) are stereotactically inoculated into basal ganglia resulting in a multinucleated giant cell encephalitis. A platelet activating factor antagonist and a matrix metalloproteinase inhibitor, which also inhibits tumor necrosis factor alpha release, were administered to animals at the time of the MDM inoculation. The drugs administered in combination markedly reduced brain inflammation, astrogliosis and microglia activation. These findings demonstrate that reduction of brain inflammatory responses, independent of viral replication, can affect HIVE pathology in an animal model system of disease.

KW - Anti-inflammatory drugs

KW - HIV-1 encephalitis

KW - Mononuclear phagocytes

UR - http://www.scopus.com/inward/record.url?scp=0035283335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035283335&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(00)00454-9

DO - 10.1016/S0165-5728(00)00454-9

M3 - Article

C2 - 11240016

AN - SCOPUS:0035283335

VL - 114

SP - 57

EP - 68

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -